Erika Morizzo

New 2-Arylpyrazolo[3,4-<i>c</i>]quinoline Derivatives as Potent and Selective Human A₃Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand−Receptor Modeling Studies

Vittoria Colotta, Daniela Catarzi, Flavia Varano et al. · Journal of Medicinal Chemistry · 2007 · 58 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

4-Amido-2-aryl-1,2,4-triazolo[4,3-<i>a</i>]quinoxalin-1-ones as New Potent and Selective Human A₃Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand−Receptor Modeling Studies

Ombretta Lenzi, Vittoria Colotta, Daniela Catarzi et al. · Journal of Medicinal Chemistry · 2006 · 56 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

2-Phenylpyrazolo[4,3-<i>d</i>]pyrimidin-7-one as a New Scaffold To Obtain Potent and Selective Human A₃Adenosine Receptor Antagonists: New Insights into the Receptor−Antagonist Recognition

Ombretta Lenzi, Vittoria Colotta, Daniela Catarzi et al. · Journal of Medicinal Chemistry · 2009 · 51 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Synthesis, ligand–receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists

Vittoria Colotta, Daniela Catarzi, Flavia Varano et al. · Bioorganic & Medicinal Chemistry · 2008 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Pyrido[2,3-<i>e</i>]-1,2,4-triazolo[4,3-<i>a</i>]pyrazin-1-one as a New Scaffold To Develop Potent and Selective Human A₃Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand−Receptor Modeling Studies

Vittoria Colotta, Ombretta Lenzi, Daniela Catarzi et al. · Journal of Medicinal Chemistry · 2009 · 36 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17